
Arcadian Microarray Technologies, Inc.
Bruner, Robert F.,...
Arcadian Microarray Technologies, Inc.
F-1496 | Published September 12, 2005 | 18 pages Case
Collection: Darden School of Business
Product Details
In August 2005, an investment manager of a hedge fund is considering purchasing an equity interest in a start-up biotechnology firm, Arcadian Microarray Technologies, Inc. The asking price is $40 million for a 60 percent equity interest. Managers of the firm are optimistic about the firm's future performance; the investment manager is more conservative in his expectations. He calls on the help of an analyst with her firm to fashion a counterproposal to Arcadian's management. The tasks for the student are to apply the concept of terminal value, interpret completed analyses and data, and derive implications of different terminal-value assumptions in an effort to recommend a counterproposal. Very little numerical figure-work is required of the student.
0
Get Ahead in Class

Clear, Complete, and Concise: Avoiding t...
Lipson, Marc L.

Business Valuation in Mergers and Acquis...
Schill, Michael J....

A Brief Introduction to Macroeconomics
Murphy, Daniel

Moral Theory, Frameworks, and the Langua...
Wicks, Andrew C.; ...

Three Empirical Methods for Calculating ...
Zhang, Zhihao; Whi...

The Basics of Multivariate Regressions i...
Batova, Tatiana

Advanced Tableau Tips and Tricks
Palomba, Anthony

Digital Marketing Metrics: Measuring Wha...
Venkatesan, Rajkum...

Disruption, Response, and Transformation...
Chen, Ming-Jer; Mc...

Using AI to Expand Your Leadership Commu...
Murray, Meghan

Understanding Organizational Culture: An...
Martin, Sean; Kemp...

A Brief Introduction to Managerial Accou...
Lynch, Luann J.

How to Prototype a Prototype
Chao, Raul O.

The Strategist’s Toolkit
Lenox, Michael; Ha...

Finance People
Schill, Michael J.